{"id":516359,"date":"2021-07-22T08:05:05","date_gmt":"2021-07-22T12:05:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/"},"modified":"2021-07-22T08:05:05","modified_gmt":"2021-07-22T12:05:05","slug":"lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/","title":{"rendered":"Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">AUSTIN, Texas, July  22, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XXPRXSQ-dPFy62XOzJCQUAdO3eGODw28FSNRxcja1NSQwAO-9-Rqf8WvsZ4ygKgONQpf_ZbrAohoVx172LYu3_7uBE02sRgsUOiKTXABJSw=\" rel=\"nofollow noopener\" target=\"_blank\">Lumos Pharma, Inc.<\/a> (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced it will report its second quarter 2021 financial results before market open on Thursday, August 5, 2021. The company will host a conference call and webcast at 11:00 AM ET that day to discuss these financial results and provide an update on clinical and corporate activities. There will be a question-and-answer session following the prepared remarks.<\/p>\n<p align=\"justify\">Investors and the general public are invited to listen to a live audio webcast of the conference call, which may be accessed five minutes prior to the start of the call by dialing (855) 469-0612 (U.S.) or (484) 756-4268 (international) or through the\u00a0link, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eah0uj5ZkrDRhTGUF5MXAVZEVk9uktxp3BiTCWCGNy_6N_3X2ZyfbiFZ-nPo2-wFIhzlBDdpHfI8FfbE4C9zs9rl3-BJ3aIzA0UN-ZNF-Nmm-yd3aoQ0ViRh3rjqNjCJCRtqbjXCQy5dBE0Hd-YajQ==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/edge.media-server.com\/mmc\/p\/kfnwndzq<\/a>. The link to the live webcast may also be found in the \u201cInvestors &amp; Media\u201d section of the Lumos Pharma website, under \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dHGqgjc9L_B4xGojlwrDVBYfLUGqZiT7jjHFhUETvEBhQvE0xMloxnpDC4mDZKehm1-0dVAQNTo4ZFUitadMHZ3hYn8ujgZ6TPzYHLOC0x12WPaEGtqtF0pyeSmrDjmhkZJbJ1x9QVpX4RoqQp5s_Q==\" rel=\"nofollow noopener\" target=\"_blank\">Events &amp; Presentations<\/a>.\u201d A replay of the call will be available for two weeks from the date of the call and may be accessed through the same link above or by dialing (855) 859-2056 (U.S.) or (404) 537-3406 (international) and using the passcode: 8050625.<\/p>\n<p align=\"justify\">\n        <strong>About Lumos Pharma<\/strong>\n      <\/p>\n<p align=\"justify\">Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. Lumos Pharma was founded and is led by a management team with longstanding experience in rare disease drug development and received early funding by leading healthcare investors, including Deerfield Management, a fund managed by Blackstone Life Sciences, Roche Venture Fund, New Enterprise Associates (NEA), Sant\u00e9 Ventures, and UCB. Lumos Pharma\u2019s lead therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule, currently being evaluated in a Phase 2 clinical trial, the OraGrowtH210 Trial, and a PK\/PD clinical trial, the OraGrowtH212 Trial, for the treatment of Pediatric Growth Hormone Deficiency (PGHD).\u00a0If approved by the FDA, LUM-201 would provide an orally administered alternative to daily injections that current PGHD patients endure for many years of treatment. LUM-201 has received Orphan Drug Designation in both the US and EU.\u00a0For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XpNo91Ir5EH4I7-AchEoTWINmKp1kz3ByBpEHcR12KIgWaexVjl0WzvT7VKF6fm8s2p7CBCHDpBq-3_8uO9q2E-a1bTAuhNOCerpbR0MQJ0=\" rel=\"nofollow noopener\" target=\"_blank\">www.lumos-pharma.com<\/a>.<\/p>\n<p align=\"justify\">Investor &amp; Media Contact:<\/p>\n<p align=\"justify\">Lisa Miller<br \/>Lumos Pharma Investor Relations<br \/>512-792-5454<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pdG35IeOmSxjHfeO-8JzKLtVhVRfakVOGVl8p_hGaiDgTZnqol0dvzdECWO2-CD4mzPOQ4VxXL2tjDDxE3GrfiG0okgmKHqUM2iE61laPK4=\" rel=\"nofollow noopener\" target=\"_blank\">ir@lumos-pharma.com<\/a><\/p>\n<p align=\"justify\">Source: Lumos Pharma, Inc.<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDYzMCM0MzA4OTEwIzIwMTY1Nzc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/b884a548-b653-4d67-a126-371a2636b885\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>AUSTIN, Texas, July 22, 2021 (GLOBE NEWSWIRE) &#8212; Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced it will report its second quarter 2021 financial results before market open on Thursday, August 5, 2021. The company will host a conference call and webcast at 11:00 AM ET that day to discuss these financial results and provide an update on clinical and corporate activities. There will be a question-and-answer session following the prepared remarks. Investors and the general public are invited to listen to a live audio webcast of the conference call, which may be accessed five minutes prior to the start of the call by dialing (855) 469-0612 (U.S.) or (484) 756-4268 (international) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-516359","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, Texas, July 22, 2021 (GLOBE NEWSWIRE) &#8212; Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced it will report its second quarter 2021 financial results before market open on Thursday, August 5, 2021. The company will host a conference call and webcast at 11:00 AM ET that day to discuss these financial results and provide an update on clinical and corporate activities. There will be a question-and-answer session following the prepared remarks. Investors and the general public are invited to listen to a live audio webcast of the conference call, which may be accessed five minutes prior to the start of the call by dialing (855) 469-0612 (U.S.) or (484) 756-4268 (international) &hellip; Continue reading &quot;Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-22T12:05:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDYzMCM0MzA4OTEwIzIwMTY1Nzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021\",\"datePublished\":\"2021-07-22T12:05:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\\\/\"},\"wordCount\":380,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NDYzMCM0MzA4OTEwIzIwMTY1Nzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\\\/\",\"name\":\"Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NDYzMCM0MzA4OTEwIzIwMTY1Nzc=\",\"datePublished\":\"2021-07-22T12:05:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NDYzMCM0MzA4OTEwIzIwMTY1Nzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NDYzMCM0MzA4OTEwIzIwMTY1Nzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/","og_locale":"en_US","og_type":"article","og_title":"Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021 - Market Newsdesk","og_description":"AUSTIN, Texas, July 22, 2021 (GLOBE NEWSWIRE) &#8212; Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, today announced it will report its second quarter 2021 financial results before market open on Thursday, August 5, 2021. The company will host a conference call and webcast at 11:00 AM ET that day to discuss these financial results and provide an update on clinical and corporate activities. There will be a question-and-answer session following the prepared remarks. Investors and the general public are invited to listen to a live audio webcast of the conference call, which may be accessed five minutes prior to the start of the call by dialing (855) 469-0612 (U.S.) or (484) 756-4268 (international) &hellip; Continue reading \"Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-22T12:05:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDYzMCM0MzA4OTEwIzIwMTY1Nzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021","datePublished":"2021-07-22T12:05:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/"},"wordCount":380,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDYzMCM0MzA4OTEwIzIwMTY1Nzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/","name":"Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDYzMCM0MzA4OTEwIzIwMTY1Nzc=","datePublished":"2021-07-22T12:05:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDYzMCM0MzA4OTEwIzIwMTY1Nzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NDYzMCM0MzA4OTEwIzIwMTY1Nzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lumos-pharma-to-report-second-quarter-2021-financial-results-and-host-conference-call-on-august-5-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lumos Pharma to Report Second Quarter 2021 Financial Results and Host Conference Call on August 5, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=516359"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516359\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=516359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=516359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=516359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}